BRIEF published on 02/20/2026 at 21:42, 1 month 8 days ago La suspension injectable d'olanzapine de Teva obtient l'approbation de la FDA Schizophrénie Olanzapine Teva Pharmaceuticals Acceptation Par La FDA Injectable À Action Prolongée
BRIEF published on 02/20/2026 at 21:42, 1 month 8 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
PRESS RELEASE published on 02/20/2026 at 21:37, 1 month 8 days ago Informations privilégiées / Autres communiqués La FDA américaine accepte le dossier de demande de mise sur le marché de l'Olanzapine LAI par Teva pour le traitement de la schizophrénie chez l'adulte. Une nouvelle option thérapeutique innovante pourrait bientôt être disponible FDA Schizophrénie Traitement Teva Olanzapine LAI
PRESS RELEASE published on 02/20/2026 at 21:37, 1 month 8 days ago Inside Information / Other news releases FDA accepts Teva's NDA for once-monthly olanzapine for schizophrenia treatment, addressing treatment gap. Teva and Medincell collaborate for innovative solution FDA Schizophrenia Medincell Olanzapine Teva
BRIEF published on 02/19/2026 at 10:33, 1 month 9 days ago Franchissement de seuil par Mirova chez MEDINCELL Euronext Paris Droits De Vote Cession D'actions Medincell Mirova
BRIEF published on 02/19/2026 at 10:33, 1 month 9 days ago Mirova crosses a threshold at MEDINCELL Euronext Paris Voting Rights Transfer Of Shares Mirova MEDICELL
PRESS RELEASE published on 02/19/2026 at 10:28, 1 month 9 days ago Franchissement de seuil Déclaration de franchissement de seuil de la société MedinCell par Mirova. Baisse à 6,44% du capital et 4,89% des droits de vote Franchissement De Seuil AMF Baisse Medincell Mirova
BRIEF published on 12/09/2025 at 14:55, 3 months 22 days ago Teva Pharmaceuticals soumet une demande d'autorisation pour Olanzapine LAI FDA Schizophrénie Medincell Teva Pharmaceuticals Olanzapine LAI
BRIEF published on 12/09/2025 at 14:55, 3 months 22 days ago Medincell and Teva Submit FDA Application for New Injectable Treatment Schizophrenia Treatment Medincell FDA Submission Teva Pharmaceuticals Olanzapine LAI
BRIEF published on 12/09/2025 at 14:55, 3 months 22 days ago Medincell et Teva soumettent une demande d'autorisation de mise sur le marché auprès de la FDA pour un nouveau traitement injectable. Traitement De La Schizophrénie Medincell Soumission À La FDA Teva Pharmaceuticals Olanzapine LAI
Published on 04/01/2026 at 08:05, 1 hour 34 minutes ago Tocvan Discovers New Gold-Silver Zone 1,600 Meters From Main Zone at South Block Gran Pilar; First Aggressive Step-Out Drilling Intersects Mineralization From Surface
Published on 04/01/2026 at 08:00, 1 hour 39 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 04/01/2026 at 04:06, 5 hours 33 minutes ago Jaguar Mining Reports Financial Results for the Fourth Quarter and Full Year 2025
Published on 04/01/2026 at 03:57, 5 hours 42 minutes ago NXT Energy Solutions Announces 2025 Year-End Results
Published on 04/01/2026 at 09:05, 34 minutes ago Solar Power to Go: Jackery Unveils SolarSaga 40 Air, the Next Generation of Compact Foldable Solar Panels
Published on 04/01/2026 at 09:05, 34 minutes ago Rockwell Automation Announces ROKStudios Video Series Launches a New Season Exploring the Journey from Automation to Autonomy
Published on 04/01/2026 at 09:00, 39 minutes ago Partners Group appoints Pete Zippelius as new Co-Head of Private Equity Health & Life
Published on 04/01/2026 at 08:00, 1 hour 39 minutes ago Transfert du contrat de liquidité aupres de Natixis Oddo BHF
Published on 04/01/2026 at 08:00, 1 hour 39 minutes ago Résultats annuels 2025 - ANR par action en hausse de + 8,1 % à 97,10 € - Fonds propres consolidés : 740 M€
Published on 03/31/2026 at 20:08, 13 hours 31 minutes ago SMTPC - Communiqué sur les résultats annuels 2025
Published on 03/31/2026 at 19:05, 14 hours 33 minutes ago SFPI GROUP: implementation of a new liquidity contract
Published on 03/31/2026 at 19:05, 14 hours 33 minutes ago Groupe SFPI : mise en oeuvre d'un nouveau contrat de liquidité
